Zydus Wellness Intrinsic Value
Zydus Wellness (ZYDUSWELL) median intrinsic value is ₹645.77 from 10 valuation models (range ₹169–₹1126), vs current price ₹563.05 — +14.7% upside (Trading Below Median Value), margin of safety 12.8%. Analyse ZYDUSWELL shareholding pattern to track promoter, FII and institutional holdings.
ZYDUSWELL Valuation Methods Summary — DCF, Graham Number & P/E
Zydus Wellness intrinsic value across 10 models vs current price ₹563.05 — upside/downside and value range per method. For current market price and key ratios, visit ZYDUSWELL screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| P/E Based Valuation | earnings | ₹244.32 | ₹195.46 - ₹293.18 | -56.6% | EPS: ₹20.36, Sector P/E: 12x |
| Book Value Method | asset | ₹910.31 | ₹819.28 - ₹1001.34 | +61.7% | Book Value/Share: ₹910.31, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹738.50 | ₹664.65 - ₹812.35 | +31.2% | Revenue/Share: ₹923.12, P/S: 0.8x |
| EBITDA Multiple Method | earnings | ₹986.25 | ₹887.62 - ₹1084.88 | +75.2% | EBITDA: ₹1052.00Cr, EV/EBITDA: 6x |
| Simple DCF (5Y) | dcf | ₹327.83 | ₹262.26 - ₹393.40 | -41.8% | CF Growth: 5.0%, Discount: 15% |
| PEG Ratio Method | growth | ₹168.91 | ₹152.02 - ₹185.80 | -70.0% | EPS Growth: 8.0%, Fair P/E: 6.4x |
| Growth Adjusted P/E | growth | ₹168.91 | ₹152.02 - ₹185.80 | -70.0% | Revenue Growth: 6.0%, Adj P/E: 8.2x |
| ROE Based Valuation | profitability | ₹1126.10 | ₹1013.49 - ₹1238.71 | +100.0% | ROE: 11.1%, P/E Multiple: 12x |
| Graham Defensive Method | conservative | ₹645.77 | ₹581.19 - ₹710.35 | +14.7% | EPS: ₹20.36, BVPS: ₹910.31 |
| Dividend Yield Method | dividend | ₹168.91 | ₹152.02 - ₹185.80 | -70.0% | DPS: ₹1.20, Target Yield: 3.5% |
ZYDUSWELL Intrinsic Value vs Market Price — All Valuation Models
Zydus Wellness fair value range ₹169–₹1126 vs current market price ₹563.05 across 10 valuation models. Read ZYDUSWELL dividend growth for the complete payout history and dividend yield track record.
ZYDUSWELL Intrinsic Value Analysis — Undervalued or Overvalued?
Zydus Wellness median intrinsic value ₹645.77, current price ₹563.05 — Trading Below Median Value by 14.7%, margin of safety 12.8%.
What is the intrinsic value of ZYDUSWELL?
Based on our comprehensive analysis using 10 different valuation methods, the estimated intrinsic value of Zydus Wellness (ZYDUSWELL) is ₹645.77 (median value). With the current market price of ₹563.05, this represents a +14.7% variance from our estimated fair value.
The valuation range spans from ₹168.91 to ₹1126.10, indicating ₹168.91 - ₹1126.10.
Is ZYDUSWELL undervalued or overvalued?
Based on our multi-method analysis, Zydus Wellness (ZYDUSWELL) appears to be trading below median value by approximately 14.7%.
ZYDUSWELL Financial Health — Key Ratios vs Industry Benchmarks
Zydus Wellness financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 0.36 | Industry Standard: 2.0+ | Below 1.5 | Measures short-term liquidity capacity |
| Return on Equity | 11.1% | Industry Standard: 15%+ | Above 10% | Measures shareholder return efficiency |
| Operating Margin | 18.0% | Industry Standard: 20%+ | Above 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.57x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
ZYDUSWELL Cash Flow Quality — Operating & Free Cash Flow
Zydus Wellness operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2026 | ₹226 Cr | ₹-1,215 Cr | Positive Operating Cash Flow | 6/10 |
| March 2025 | ₹380 Cr | ₹277 Cr | Positive Free Cash Flow | 8/10 |
| March 2024 | ₹246 Cr | ₹157 Cr | Positive Free Cash Flow | 8/10 |
| March 2023 | ₹92 Cr | ₹50 Cr | Positive Free Cash Flow | 8/10 |
| March 2022 | ₹237 Cr | ₹208 Cr | Positive Free Cash Flow | 8/10 |